Buchumschlag

Protective effect of regular physical activity against diabetes‐related lower extremity amputation

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jae Won Kim, Kyung‐Do Han, Jun Hyeok Kim, Yoon Jae Lee
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Journal of Diabetes
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Diabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
von: Jinsun Jang, et al.
Veröffentlicht: (2026)

Betagenin: New intestine‐derived hormone which ameliorates diabetes
von: Yong Kyung Kim, et al.
Veröffentlicht: (2025)

Commentary on “Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”
von: Mostafa Javanian, et al.
Veröffentlicht: (2024)

Response to “Commentary on factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”
von: Alexander J. Eckert, et al.
Veröffentlicht: (2024)

Glucose metabolism partially regulates β‐cell function through epigenomic changes
von: Yong Kyung Kim, et al.
Veröffentlicht: (2024)

Risk of end‐stage renal disease in Korean patients with type 2 diabetes according to cumulative low‐density lipoprotein cholesterol levels
von: Da‐Yeon Lee, et al.
Veröffentlicht: (2026)

Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population‐Based Comparison
von: Ji Eun Jun, et al.
Veröffentlicht: (2026)

Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy
von: Ye Eun Han, et al.
Veröffentlicht: (2026)

A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study
von: Tae Seo Sohn, et al.
Veröffentlicht: (2024)

Artificial intelligence‐based body composition analysis using computed tomography images predicts both prevalence and incidence of diabetes mellitus
von: Yoo Hyung Kim, et al.
Veröffentlicht: (2024)

Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity
von: Jae Hyun Bae, et al.
Veröffentlicht: (2024)

Gamma‐glutamyl transferase and the risk of all‐cause and disease‐specific mortality in patients with diabetes: A nationwide cohort study
von: Goh Eun Chung, et al.
Veröffentlicht: (2024)

Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study
von: In‐Kyung Jeong, et al.
Veröffentlicht: (2024)

Effects of high‐intensity interval walking training on muscle strength, walking ability, and health‐related quality of life in people with diabetes accompanied by lower extremity weakness: A randomized controlled trial
von: Yasuko Ichihara, et al.
Veröffentlicht: (2025)

A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
von: Soo Lim, et al.
Veröffentlicht: (2024)

Corrigendum to “Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress‐Related Retinal Pericyte Loss in Streptozotocin‐Induced Diabetic Mice”
von: Yoo-Ri Chung, et al.
Veröffentlicht: (2024)

Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial
von: Soo Heon Kwak, et al.
Veröffentlicht: (2024)

Two decades of diabetes prevention: Sustained benefits, heterogeneous effects, and implications for precision prevention
von: Seung‐Hwan Lee
Veröffentlicht: (2025)

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24‐week, randomized, open‐label, multicenter trial
von: So Ra Kim, et al.
Veröffentlicht: (2026)

Effectiveness of wearable technology‐based physical activity interventions for adults with type 2 diabetes mellitus: A systematic review and meta‐regression
von: Rachael Ern Ching Chua, et al.
Veröffentlicht: (2024)

Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta‐analysis with focus on an Asian subpopulation
von: Myung Jin Kim, et al.
Veröffentlicht: (2025)

Mitochondrial ALDH2 improves ß‐cell survival and function against doxorubicin‐induced apoptosis by targeting CK2 signaling
von: Udayakumar Karunakaran, et al.
Veröffentlicht: (2024)

Association between diabetic peripheral neuropathy and lower limb muscle strength in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
von: Yuki Nakashima, et al.
Veröffentlicht: (2025)

Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP ‐4 inhibitors: A multicentre, phase 4 randomized controlled trial
von: Yun Kyung Cho, et al.
Veröffentlicht: (2025)

Gut microbiota, serum metabolites, and lipids related to blood glucose control and type 1 diabetes
von: Zhaohe Gu, et al.
Veröffentlicht: (2024)

Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes
von: Guk Jin Lee, et al.
Veröffentlicht: (2026)

Response to the letter to the editor regarding “Association between diabetic peripheral neuropathy and lower limb muscle strength in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis”
von: Yuki Nakashima, et al.
Veröffentlicht: (2026)

β‐Cell dysfunction in diabetes: The role of neuroplastin
von: Moon‐Kyu Lee
Veröffentlicht: (2025)

Age‐related variations in clinical characteristics of patients with diabetic foot ulcers
von: Hong‐ping Gong, et al.
Veröffentlicht: (2025)

Retrospective database study on risk factors for diabetic retinopathy and diabetic kidney disease in Japanese patients with diabetes mellitus
von: Kota Yamada, et al.
Veröffentlicht: (2024)

Physical activity modifies the association between atherogenic index of plasma and prediabetes and diabetes: A cross‐sectional analysis
von: Shenglan Yang, et al.
Veröffentlicht: (2024)

Correction to “Association between variation in hemoglobin A1c levels and diabetes therapy‐related quality of life in patients with diabetes”
Veröffentlicht: (2024)

Islet transplantation in Korea
von: Joonyub Lee, et al.
Veröffentlicht: (2024)

Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records
von: Haowen Hsu, et al.
Veröffentlicht: (2024)

Development of a diagnostic model of insulin‐related lipohypertrophy for patients with diabetes mellitus
von: Xiaohui Li, et al.
Veröffentlicht: (2025)

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate
von: Andrzej S. Januszewski, et al.
Veröffentlicht: (2024)

The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma
von: Yutaka Seino, et al.
Veröffentlicht: (2024)

Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study
von: Seunghwan Baek, et al.
Veröffentlicht: (2024)

Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study
von: Yu Jiang, et al.
Veröffentlicht: (2024)

Protective effects of 23‐valent pneumococcal polysaccharide vaccination against mortality among elder patients with type 2 diabetes mellitus
von: Xiaoling Peng, et al.
Veröffentlicht: (2026)